 A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
 C CARDIOVASCULAR SYSTEM
|
C01 CARDIAC THERAPY
|
C02 ANTIHYPERTENSIVES
|
C03 DIURETICS
|
C04 PERIPHERAL VASODILATORS
|
C05 VASOPROTECTIVES
|
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
|
C05AA Corticosteroids
|
C05AA01 Hydrocortisone [DG:DG00012]
|
C05AA04 Prednisolone [DG:DG00093]
|
C05AA05 Betamethasone [DG:DG00095]
|
 D00244 Betamethasone (JP19/USP/INN) <JP>
D00972 Betamethasone sodium phosphate (JP19/USP) <JP>
D01357 Betamethasone valerate (JP19/USP) <JP/US>
D01402 Betamethasone acetate (JAN/USP)
D01637 Betamethasone dipropionate (JP19/USP) <JP/US>
D02032 Betamethasone butyrate propionate (JAN) <JP>
D02286 Betamethasone benzoate (USP)
|
C05AA06 Fluorometholone [DG:DG00294]
|
C05AA08 Fluocortolone [DG:DG00295]
|
C05AA09 Dexamethasone [DG:DG00011]
|
C05AA10 Fluocinolone acetonide
|
C05AA11 Fluocinonide
|
C05AA12 Triamcinolone [DG:DG00010]
|
C05AB Antibiotics
|
C05AD Local anesthetics
|
C05AE Muscle relaxants
|
C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
|
C05B ANTIVARICOSE THERAPY
|
C05C CAPILLARY STABILIZING AGENTS
|
C05X OTHER VASOPROTECTIVES
|
C07 BETA BLOCKING AGENTS
|
C08 CALCIUM CHANNEL BLOCKERS
|
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
C10 LIPID MODIFYING AGENTS
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification